Connection

KEVIN MACKENZIE to Microsomes, Liver

This is a "connection" page, showing publications KEVIN MACKENZIE has written about Microsomes, Liver.
Connection Strength

0.947
  1. Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine. Eur J Pharm Sci. 2020 Oct 01; 153:105488.
    View in: PubMed
    Score: 0.678
  2. Metabolism of JQ1, an inhibitor of bromodomain and extra terminal bromodomain proteins, in human and mouse liver microsomes?. Biol Reprod. 2020 08 04; 103(2):427-436.
    View in: PubMed
    Score: 0.170
  3. Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC-MS-Based Metabolomic Approaches. Chem Res Toxicol. 2023 08 21; 36(8):1427-1438.
    View in: PubMed
    Score: 0.052
  4. Metabolism of a Selective Serotonin and Norepinephrine Reuptake Inhibitor Duloxetine in Liver Microsomes and Mice. Drug Metab Dispos. 2022 02; 50(2):128-139.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.